Triple-Negative Breast Cancer

>

Latest News

From Clinical Trials to Real-World Practice, Experts Examine the Best Options for TNBC
From Clinical Trials to Real-World Practice, Experts Examine the Best Options for TNBC

February 4th 2023

During a live Tweet Chat, Hope S. Rugo, MD, and Paolo Tarantino, MD, reviewed a patient case and discussed current standard of care for those with metastatic triple-negative breast cancer.

Recap: The Use of Sacituzumab Govitecan in Triple-Negative Breast Cancer
Recap: The Use of Sacituzumab Govitecan in Triple-Negative Breast Cancer

February 1st 2023

Cisplatin plus veliparib appears to improve progression-free survival among patients with BRCA-like metastatic triple-negative breast cancer, but not in those with non–BRCA-like metastatic breast cancer.
Veliparib/Cisplatin May Improve Survival Vs Placebo in BRCA-Like Metastatic TNBC

January 19th 2023

Patients with HER2-positive breast cancer and triple-negative breast cancer may not require breast surgery if a pathological complete response can be identified using image-guided vacuum core biopsy following neoadjuvant systemic therapy.
Image-Guided Vacuum Core Biopsy May Identify CR in HER2+ Breast Cancer and TNBC Following Neoadjuvant Therapy

January 14th 2023

Trilaciclib Prior to Sacituzumab Govitecan-hziy Appeared to Reduce AEs in Advanced TNBC
Trilaciclib Prior to Sacituzumab Govitecan-hziy Appeared to Reduce AEs in Advanced TNBC

November 3rd 2022

Video Interviews
Podcasts

More News